×

What are you searching for?




Pharmaceuticals

4 Min read

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Published On 04 Aug 2020 08:03 AM


SHARE THIS ARTICLE  


Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 trials, the SII has to submit safety data evaluated by the DSMB said a senior government official

Taking the country one step closer towards the....


Tags : Covishield, COVID-19 vaccine, Serum Institute of India, SII, Oxford University, DCGI,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)